Close Menu

NEW YORK – Irvine, California-based Genomic Testing Cooperative (GTC) said on Tuesday it is collaborating with C2i Genomics to develop liquid biopsy tests for solid tumor staging and monitoring.

GTC will sequence samples and help with technical and clinical validation, while C2I will be responsible for artificial intelligence-based analysis of data, recruitment of samples, and various clinical trial activities. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.